|
1
|
Friedman SL: Mechanisms of hepatic
fibrogenesis. Gastroenterology. 134:1655–1669. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Fallowfield JA: Therapeutic targets in
liver fibrosis. Am J Physiol Gastrointest Liver Physiol.
300:G709–G715. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Olson JC and Saeian K: Gastrointestinal
issues in liver disease. Crit Care Clin. 32:371–384. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Pazirandeh S, Khettry U, Gordon FD,
Resnick RH, Murray JE and Sheth SG: Cyclooxygenase-2 expression in
hepatocellular carcinoma, cirrhosis and chronic hepatitis in the
United States. Dig Dis Sci. 52:220–227. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Simmons DL, Botting RM and Hla T:
Cyclooxygenase isozymes: The biology of prostaglandin synthesis and
inhibition. Pharmacol Rev. 56:387–437. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Jeong SW, Jang JY, Lee SH, Kim SG, Cheon
YK, Kim YS, Cho YD, Kim HS, Lee JS, Jin SY, et al: Increased
expression of cyclooxygenase-2 is associated with the progression
to cirrhosis. Korean J Intern Med. 25:364–371. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhou JY, Jiang ZA, Zhao CY, Zhen Z, Wang W
and Nanji AA: Long-term binge and escalating ethanol exposure
causes necroinflammation and fibrosis in rat liver. Alcohol Clin
Exp Res. 37:213–222. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Gao JH, Wen SL, Yang WJ, Lu YY, Tong H,
Huang ZY, Liu ZX and Tang CW: Celecoxib ameliorates portal
hypertension of the cirrhotic rats through the dual inhibitory
effects on the intrahepatic fibrosis and angiogenesis. PLoS One.
8:e693092013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wen SL, Gao JH, Yang WJ, Lu YY, Tong H,
Huang ZY, Liu ZX and Tang CW: Celecoxib attenuates hepatic
cirrhosis through inhibition of epithelial-to-mesenchymal
transition of hepatocytes. J Gastroenterol Hepatol. 29:1932–1942.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yu J, Hui AY, Chu ES, Go MY, Cheung KF, Wu
CW, Chan HL and Sung JJ: The anti-inflammatory effect of celecoxib
does not prevent liver fibrosis in bile duct-ligated rats. Liver
Int. 29:25–36. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Holt AP and Adams DH: Complex roles of
cyclo-oxygenase 2 in hepatitis. Gut. 56:903–904. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Peng W and Fan H: Long non-coding RNA
PANDAR correlates with poor prognosis and promotes tumorigenesis in
hepatocellular carcinoma. Biomed Pharmacother. 72:113–118. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hung T and Chang HY: Long noncoding RNA in
genome regulation: Prospects and mechanisms. RNA Biol. 7:582–585.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang KC, Yang YW, Liu B, Sanyal A,
Corces-Zimmerman R, Chen Y, Lajoie BR, Protacio A, Flynn RA, Gupta
RA, et al: A long noncoding RNA maintains active chromatin to
coordinate homeotic gene expression. Nature. 472:120–124. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Guttman M, Donaghey J, Carey BW, Garber M,
Grenier JK, Munson G, Young G, Lucas AB, Ach R, Bruhn L, et al:
lincRNAs act in the circuitry controlling pluripotency and
differentiation. Nature. 477:295–300. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Mourtada-Maarabouni M, Hedge VL, Kirkham
L, Farzaneh F and Williams GT: Growth arrest in human T-cells is
controlled by the non-coding RNA growth-arrest-specific transcript
5 (GAS5). J Cell Sci. 121:939–946. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yang X, Xie X, Xiao YF, Xie R, Hu CJ, Tang
B, Li BS and Yang SM: The emergence of long non-coding RNAs in the
tumorigenesis of hepatocellular carcinoma. Cancer Lett.
360:119–124. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Sun J, Bie B, Zhang S, Yang J and Li Z:
Long non-coding RNAs: Critical players in hepatocellular carcinoma.
Int J Mol Sci. 15:20434–20448. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Tong Q, Gong AY, Zhang XT, Lin C, Ma S,
Chen J, Hu G and Chen XM: LincRNA-Cox2 modulates TNF-α-induced
transcription of Il12b gene in intestinal epithelial cells through
regulation of Mi-2/NuRD-mediated epigenetic histone modifications.
FASEB J. 30:1187–1197. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Carpenter S, Aiello D, Atianand MK, Ricci
EP, Gandhi P, Hall LL, Byron M, Monks B, Henry-Bezy M, Lawrence JB,
et al: A long noncoding RNA mediates both activation and repression
of immune response genes. Science. 341:789–792. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Xu WH, Zhang JB, Dang Z, Li X, Zhou T, Liu
J, Wang DS, Song WJ and Dou KF: Long non-coding RNA URHC regulates
cell proliferation and apoptosis via ZAK through the ERK/MAPK
signaling pathway in hepatocellular carcinoma. Int J Biol Sci.
10:664–676. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
He Y, Wu YT, Huang C, Meng XM, Ma TT, Wu
BM, Xu FY, Zhang L, Lv XW and Li J: Inhibitory effects of long
noncoding RNA MEG3 on hepatic stellate cells activation and liver
fibrogenesis. Biochim Biophys Acta. 1842:2204–2215. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method). Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hernandez-Gea V and Friedman SL:
Pathogenesis of liver fibrosis. Annu Rev Pathol. 6:425–456. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Giannitrapani L, Ingrao S, Soresi M,
Florena AM, La Spada E, Sandonato L, D'Alessandro N, Cervello M and
Montalto G: Cyclooxygenase-2 expression in chronic liver diseases
and hepatocellular carcinoma: An immunohistochemical study. Ann N Y
Acad Sci. 1155:293–299. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Mohammed NA, Abd E, l-Aleem SA, El-Hafiz
HA and McMahon RF: Distribution of constitutive (COX-1) and
inducible (COX-2) cyclooxygenase in postviral human liver
cirrhosis: A possible role for COX-2 in the pathogenesis of liver
cirrhosis. J Clin Pathol. 57:350–400. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhao Y, Wang Y, Wang Q, Liu Z, Liu Q and
Deng X: Hepatic stellate cells produce vascular endothelial growth
factor via phospho-p44/42 mitogen-activated protein
kinase/cyclooxygenase-2 pathway. Mol Cell Biochem. 359:217–223.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Sacerdoti D, Pesce P, Di Pascoli M, Brocco
S, Cecchetto L and Bolognesi M: Arachidonic acid metabolites and
endothelial dysfunction of portal hypertension. Prostaglandins
Other Lipid Mediat. 120:80–90. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Hu H, Jing X, Zou X and Wu J: Role of
cyclooxygenase 2 and its inhibitor valdecoxib in liver fibrosis.
Zhonghua Yi Xue Za Zhi. 94:784–787. 2014.(In Chinese). PubMed/NCBI
|
|
30
|
He Y, Meng XM, Huang C, Wu BM, Zhang L, Lv
XW and Li J: Long noncoding RNAs: Novel insights into hepatocelluar
carcinoma. Cancer Lett. 344:20–27. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yoon JH, Abdelmohsen K and Gorospe M:
Posttranscriptional gene regulation by long noncoding RNA. J Mol
Biol. 425:3723–3730. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kitagawa M, Kotake Y and Ohhata T: Long
non-coding RNAs involved in cancer development and cell fate
determination. Curr Drug Targets. 13:1616–1621. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wang F, Xie C, Zhao W, Deng Z, Yang H and
Fang Q: Long non-coding RNA CARLo-5 expression is associated with
disease progression and predicts outcome in hepatocellular
carcinoma patients. Clin Exp Med. Oct 3–2015.(Epub ahead of
print).
|
|
34
|
Lai MC, Yang Z, Zhou L, Zhu QQ, Xie HY,
Zhang F, Wu LM, Chen LM and Zheng SS: Long non-coding RNA MALAT-1
overexpression predicts tumor recurrence of hepatocellular
carcinoma after liver transplantation. Med Oncol. 29:1810–1816.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Rouzer CA and Marnett LJ: Cyclooxygenases:
Structural and functional insights. J Lipid Res. 50(50 Suppl):
S29–S34. 2009.PubMed/NCBI
|
|
36
|
Efsen E, Bonacchi A, Pastacaldi S, Valente
AJ, Wenzel UO, Tosti-Guerra C, Pinzani M, Laffi G, Abboud HE,
Gentilini P and Marra F: Agonist-specific regulation of monocyte
chemoattractant protein-1 expression by cyclooxygenase metabolites
in hepatic stellate cells. Hepatology. 33:713–721. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Hui AY, Cheng AS, Chan HL, Go MY, Chan FK,
Sakata R, Ueno T, Sata M and Sung JJ: Effect of prostaglandin E2
and prostaglandin I2 on PDGF-induced proliferation of LI90, a human
hepatic stellate cell line. Prostaglandins Leukot Essent Fatty
Acids. 71:329–333. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Kawada N: Evolution of hepatic fibrosis
research. Hepatol Res. 41:199–208. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Matsui M, Chu Y, Zhang H, Gagnon KT,
Shaikh S, Kuchimanchi S, Manoharan M, Corey DR and Janowski BA:
Promoter RNA links transcriptional regulation of inflammatory
pathway genes. Nucleic Acids Res. 41:10086–10109. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Krawczyk M and Emerson BM: p50-associated
COX-2 extragenic RNA (PACER) activates COX-2 gene expression by
occluding repressive NF-αB complexes. Life. 3:e017762014.
|
